SITC 2024
Unleashing tools to accelerate
breakthroughs in human health
SITC 2024
Unleashing tools to accelerate
breakthroughs in human health
We’re looking forward to attending SITC 2024! The Society for Immunotherapy of Cancer’s 39th Annual Meeting will take place from November 6–10 in Houston, TX. The largest cancer immunotherapy conference will bring together industry representatives as well as international leaders from academia, regulatory and government agencies for education, scientific exchange and networking with scientists driving the field. SITC 2024 will also include updates on major national and international initiatives from academia, government and industry, cutting-edge research presentations by experts in the field and oral and poster abstract presentations.
Standard BioTools™ is proud to join researchers, clinicians, patients, industry leaders and other healthcare professionals to help advance the science and application of cancer immunotherapy worldwide and improve outcomes for cancer patients. Visit us at Booth 601 to learn more about how our key tools and technologies can help expedite biomarker discovery and shed light on how the immune system responds to cancer and potential immunotherapy treatments.
SITC 2024
Advance the science, discover breakthroughs and educate the world on cancer immunotherapy.
George R. Brown Convention Center Houston, TX USA
The Hyperion XTi™ Imaging System
The fastest and most reliable workflow for high-plex imaging, enabling throughput and precision that is uniquely designed for translational and clinical researchers. IMC™ allows you to accurately visualize and quantify cells to reveal mechanisms of action that impact disease progression and therapeutic outcomes and investigate the spatial biology of the complex tumor microenvironment to advance immuno-oncology studies.
Book a slot to unlock what's new in spatial proteomics and receive a special giveaway.
CyTOF XT™ provides reproducible and standardized workflows
Simple and easy-to-modify panel design and precise measurement of all markers. Featured in over 2,000 publications and 200 clinical trials, CyTOF technology empowers investigators to interrogate more than 50 markers simultaneously on millions of individual cells, unveiling new cell types, functions and biomarkers in immunology, cancer and more.
The SomaScan Platform provides the most comprehensive proteomic coverage
The highest precision for cancer research, maximizing target selection and validation. The platform advances insights at every stage of disease research and treatment by simultaneously profiling 11,000 protein measurements. This helps researchers identify proteins and protein networks related to the origin, proliferation, and metastasis of solid tumors and blood-based cancers, driving early discovery and validation for translational science and preclinical research.
The Biomark™ X9 System for High-Throughput Genomics
The only genomics system on the market that can perform both real-time PCR and next-generation sequencing library preparation to support discovery through screening. This versatile microfluidics-based benchtop platform delivers thousands of nanoliter-scale reactions in a single run, providing a sensitive and cost-effective toolset for enabling tumor immunobiology profiling and new biomarker identification.
Book a slot to unveil whats new in genomics and receive a special giveaway.
Scientific posters on a variety of subject matter will be presented
Friday, November 8 | 5:30–7:00pm
- Poster 1377: Imaging Mass Cytometry Approach Unveils Extensive Cellular Heterogeneity in Human Brain Tumors
- Poster 79: Revealing Immunological Spatial Landscape of Mouse Neural Tissues Using Imaging Mass Cytometry Approach
- Poster 287: Functional Characterization of CAR T Cell Activation, Exhaustion and Cytokine Production With a 52-Plex CyTOF Assay
- Poster 103: A Deep-Learning Approach to Guide Acquisition Region Selection for Imaging Mass Cytometry
Saturday, November 9 | 7:10–8:40pm
- Poster 150: Enabling Rapid and Convenient Human Immune Profiling in Fresh and Long-Term Stabilized Whole Blood Samples With CyTOF Flow Cytometry
- Poster 80: Advanced Spatial Profiling of Tumor Microenvironment Using Imaging Mass Cytometry Approach: High-Plex Analysis of T Cell Exhaustion Markers for Immunotherapy Studies
- Poster 1362: Whole Slide Imaging Modes and Curated Antibody Panels for Imaging Mass Cytometry Approach Reveal Extensive Spatial Heterogeneity of Human Glioblastomas